Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BTGD | 23.15 | 0.30 | +1.33% |
| STKd 100% Bitcoin & 100% Gold ETF (BTGD) | |||
| SDG | 86.90 | 0.27 | +0.31% |
| iShares MSCI Global Sustainable Development Goals ETF (SDG) | |||
| MMU | 9.49 | 0.01 | +0.11% |
| Western Asset Managed Municipals Fund | |||
| ALRG | 30.89 | N/A | N/A |
| Allspring LT Large Core ETF (ALRG) | |||
| HYD | 49.02 | -0.32 | -0.65% |
| VanEck High Yield Muni ETF (HYD) | |||
A.I.dvisor indicates that over the last year, IKT has been loosely correlated with MLYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then MLYS could also see price increases.
| Ticker / NAME | Correlation To IKT | 1D Price Change % | ||
|---|---|---|---|---|
| IKT | 100% | -3.90% | ||
| MLYS - IKT | 41% Loosely correlated | +2.83% | ||
| EDIT - IKT | 37% Loosely correlated | +1.17% | ||
| BNTC - IKT | 37% Loosely correlated | -1.06% | ||
| VIR - IKT | 37% Loosely correlated | +2.00% | ||
| ENTA - IKT | 36% Loosely correlated | -0.58% | ||
More | ||||
Industry Biotechnology
The RSI Indicator for IKT moved into overbought territory on November 03, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for IKT just turned positive on October 29, 2026. Looking at past instances where IKT's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.
Following a +6.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where IKT advanced for three days, in 196 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IKT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for IKT entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.424) is normal, around the industry mean (3.051). P/E Ratio (-3.557) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).
The Tickeron Seasonality Score of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. IKT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.